Funding for this research was provided by:
National Institutes of Health (5T32HL007093)
Bristol-Myers Squibb (NCT02488759)
National Cancer Institute (P30 CA015704)
Text and Data Mining valid from 2018-08-31
Received: 26 March 2018
Accepted: 14 August 2018
First Online: 31 August 2018
Ethics approval and consent to participate
: The patient had provided informed consent for sharing his information on a research protocol approved by the University of Washington/Fred Hutchison Cancer Research Center IRB.
: The patient and his wife had provided consent for the use of the medical information contained in this case report for research and publication.
: SB reports institutional research (to UW) funding from Merck, Bristol Myers Squibb (BMS) and EMD-Serono. SB has participated in advisory boards, receiving honoraria, sponsored by Bristol Myers Squibb (BMS), Genentech and EMD-Serono. PN reports acting as a consultant for EMD Serono, Merck and Pfizer and his laboratory has received research funding from BMS & EMD Serono. The remaining authors declare that they have no competing financial interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.